I saw a poster at a conference that presented data suggesting that by altering the pH and/or the volume of 4% PFA during transcardial perfusion it is possible to tailor the fix for optimal labeling with individual antibodies.  Does anyone have any experience with this?

More Justin Andrew Smith's questions See All
Similar questions and discussions